BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 26510838)

  • 1. Flux-sum analysis identifies metabolite targets for strain improvement.
    Lakshmanan M; Kim TY; Chung BK; Lee SY; Lee DY
    BMC Syst Biol; 2015 Oct; 9():73. PubMed ID: 26510838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic engineering of Escherichia coli and in silico comparing of carboxylation pathways for high succinate productivity under aerobic conditions.
    Yang J; Wang Z; Zhu N; Wang B; Chen T; Zhao X
    Microbiol Res; 2014; 169(5-6):432-40. PubMed ID: 24103861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSDesign: Computational metabolic pathway design based on flux variability using elementary flux modes.
    Toya Y; Shiraki T; Shimizu H
    Biotechnol Bioeng; 2015 Apr; 112(4):759-68. PubMed ID: 25408191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic engineering of Escherichia coli for enhanced production of succinic acid, based on genome comparison and in silico gene knockout simulation.
    Lee SJ; Lee DY; Kim TY; Kim BH; Lee J; Lee SY
    Appl Environ Microbiol; 2005 Dec; 71(12):7880-7. PubMed ID: 16332763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-scale in silico aided metabolic analysis and flux comparisons of Escherichia coli to improve succinate production.
    Wang Q; Chen X; Yang Y; Zhao X
    Appl Microbiol Biotechnol; 2006 Dec; 73(4):887-94. PubMed ID: 16927085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico design of anaerobic growth-coupled product formation in Escherichia coli: experimental validation using a simple polyol, glycerol.
    Balagurunathan B; Jain VK; Tear CJ; Lim CY; Zhao H
    Bioprocess Biosyst Eng; 2017 Mar; 40(3):361-372. PubMed ID: 27796571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flux-sum analysis: a metabolite-centric approach for understanding the metabolic network.
    Chung BK; Lee DY
    BMC Syst Biol; 2009 Dec; 3():117. PubMed ID: 20021680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of alternative metabolic pathways diverts carbon flux away from isobutanol formation in an engineered Escherichia coli strain.
    Deb SS; Reshamwala SMS; Lali AM
    Biotechnol Lett; 2019 Jul; 41(6-7):823-836. PubMed ID: 31093837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Batch culture characterization and metabolic flux analysis of succinate-producing Escherichia coli strains.
    Sánchez AM; Bennett GN; San KY
    Metab Eng; 2006 May; 8(3):209-26. PubMed ID: 16434224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulating pyruvate to acetyl-CoA conversion in Escherichia coli for anaerobic succinate biosynthesis from glucose with the yield close to the stoichiometric maximum.
    Skorokhodova AY; Morzhakova AA; Gulevich AY; Debabov VG
    J Biotechnol; 2015 Nov; 214():33-42. PubMed ID: 26362413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering the Escherichia coli fermentative metabolism.
    Orencio-Trejo M; Utrilla J; Fernández-Sandoval MT; Huerta-Beristain G; Gosset G; Martinez A
    Adv Biochem Eng Biotechnol; 2010; 121():71-107. PubMed ID: 20182928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel whole-phase succinate fermentation strategy with high volumetric productivity in engineered Escherichia coli.
    Li Y; Li M; Zhang X; Yang P; Liang Q; Qi Q
    Bioresour Technol; 2013 Dec; 149():333-40. PubMed ID: 24125798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a metabolic engineering strain "commons": an Escherichia coli platform strain for ethanol production.
    Woodruff LB; May BL; Warner JR; Gill RT
    Biotechnol Bioeng; 2013 May; 110(5):1520-6. PubMed ID: 23322646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical, genetic, and metabolic engineering strategies to enhance coproduction of 1-propanol and ethanol in engineered Escherichia coli.
    Srirangan K; Liu X; Westbrook A; Akawi L; Pyne ME; Moo-Young M; Chou CP
    Appl Microbiol Biotechnol; 2014 Nov; 98(22):9499-515. PubMed ID: 25301579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative fluxome and metabolome analysis for overproduction of succinate in Escherichia coli.
    Taymaz-Nikerel H; De Mey M; Baart GJ; Maertens J; Foulquié-Moreno MR; Charlier D; Heijnen JJ; van Gulik WM
    Biotechnol Bioeng; 2016 Apr; 113(4):817-29. PubMed ID: 26444867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico co-factor balance estimation using constraint-based modelling informs metabolic engineering in Escherichia coli.
    de Arroyo Garcia L; Jones PR
    PLoS Comput Biol; 2020 Aug; 16(8):e1008125. PubMed ID: 32776925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a Genome-Scale Metabolic Model of Arthrospira platensis NIES-39 and Metabolic Design for Cyanobacterial Bioproduction.
    Yoshikawa K; Aikawa S; Kojima Y; Toya Y; Furusawa C; Kondo A; Shimizu H
    PLoS One; 2015; 10(12):e0144430. PubMed ID: 26640947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic pathway engineering for the non-growth-associated succinate production in Escherichia coli based on flux solution space.
    Toya Y; Shimizu H
    J Biosci Bioeng; 2022 Jul; 134(1):29-33. PubMed ID: 35545466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current advances of succinate biosynthesis in metabolically engineered Escherichia coli.
    Zhu LW; Tang YJ
    Biotechnol Adv; 2017 Dec; 35(8):1040-1048. PubMed ID: 28939498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico metabolic pathway analysis and design: succinic acid production by metabolically engineered Escherichia coli as an example.
    Lee SY; Hong SH; Moon SY
    Genome Inform; 2002; 13():214-23. PubMed ID: 14571390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.